Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial

Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

October 28, 2022

Global Healthcare Management is active management and distributions program. It will gain knowledge of the established and emerging concept.

September 15, 2022
Market Insights

Skylight Health Group is a healthcare services and technology company, working to positively impact patient health outcomes.

September 13, 2022

Rakovina Therapeutics Inc. is focused on the development of new cancer treatments based on novel DNA-damage response (DDR) technologies.

May 20, 2022